Can H Ficicioglu MD PhD
Clinical Biochemical Genetics, Clinical Genetics
Professor of Pediatrics, Perelman School of Medicine
Join to View Full Profile
3401 Civic Center BlvdChildrens Hospital of Philadelphia MetabolismPhiladelphia, PA 19104
Phone+1 215-590-3376
Fax+1 215-590-4297
Dr. Ficicioglu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Westchester Medical CenterResidency, Pediatrics, 2001 - 2002
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2000 - 2001
Mass General Brigham/Brigham and Women's Hospital/Children's Hospital/Harvard Medical SchoolResidency, Internal Medicine/Pediatrics, 1998 - 1999
Istanbul University FomClass of 1985
Certifications & Licensure
NJ State Medical License 2016 - 2027
PA State Medical License 2002 - 2026
NC State Medical License 2022 - 2022
NY State Medical License 2002 - 2004
American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
American Board of Pediatrics Pediatrics
Clinical Trials
- Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN Therapy Start of enrollment: 2010 Mar 01
- Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric ENT Surgery (The HATT Project) Start of enrollment: 2014 May 21
- A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders Start of enrollment: 2014 Dec 31
- Join now to see all
Publications & Presentations
PubMed
- Safety and efficacy of pegtibatinase enzyme replacement therapy in adults with classical homocystinuria in the COMPOSE phase 1/2 randomized trial.Can Ficicioglu, Janet A Thomas, Jaya Ganesh, David Kudrow, Melissa Lah
Genetics in Medicine. 2025-05-14 - Newborn Screening for Gaucher Disease: The New Jersey Experience.Caitlin Menello, Shaney Pressley, Madeline Steffensen, Sarah Schmidt, Helio Pedro
International Journal of Neonatal Screening. 2025-05-02 - Five-Year Outcomes of Patients with Pompe Disease Identified by the Pennsylvania Newborn Screen.Hayley A Ron, Owen Kane, Rose Guo, Caitlin Menello, Nicole Engelhardt
International Journal of Neonatal Screening. 2025-02-24
Journal Articles
- TANGO2: Expanding the Clinical Phenotype and Spectrum of Pathogenic VariantsJennifer N Dines, Heather C Mefford, Barbara Burton, Joline Dalton, Alice Basinger, Peter Karachunski, Can Ficicioglu, Katherine L Helbig, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
